< Return to Search Results

Drug Details

Drug Number:	454/08
Drug Name:	nelarabine (Atriance)
Drug Manufacturer:	GlaxoSmithKline UK
BNF Category:	Malignant disease and immunosuppression
Submission type :	Full submission
Date Advice Issued:	07 April 2008
Indication:	For the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)

Drug Advice

nelarabine (Atriance)

Press Statement

Read the press statement

Read the media briefing

Minutes

Read the minutes

Notes

< Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product

SEARCH FOR A DRUG

UNKNOWN - All BNF Categories - AnaesthesiaCardiovascular systemCentral nervous systemEar, nose and oropharynxEndocrine systemEyeGastro-intestinal systemImmunological products and vaccinesInfectionsMalignant disease and immunosuppressionMusculoskeletal and joint diseasesNutrition and bloodObstetrics, gynaecology, and urinary-tract disordersRespiratory systemSkin

UNKNOWN - All Types of Submission - Abbreviated SubmissionFull submissionIRPNon submissionResubmission

Help on how to improve your search.